Evidence map›Paper›PMID 33228140›Full record

ReviewMaterials (Basel, Switzerland)2020

A Short Review on Biomedical Applications of Nanostructured Bismuth Oxide and Related Nanomaterials.

Mattia Bartoli, Pravin Jagdale, Alberto Tagliaferro

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The role of bismuth nanoparticles in the inhibition of bacterial infection.World journal of microbiology & biotechnology · 2023
    Review
  9. Surface Modification of BiMolecules (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Guayule Natural Rubber Latex and BiMaterials (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Rapid Fabrication of MgNHBiomedicines · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mattia BartoliDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy.ORCID 0000-0002-4678-0212
Pravin JagdaleConsorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM), Via G. Giusti 9, 50121 Florence, Italy.ORCID 0000-0002-2486-0326
Alberto TagliaferroDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy.ORCID 0000-0003-1607-5624

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review, we reported the main achievements reached by using bismuth oxides and related materials for biological applications. We overviewed the complex chemical behavior of bismuth during the transformation of its compounds to oxide and bismuth oxide phase transitions. Afterward, we summarized the more relevant studies regrouped into three categories based on the use of bismuth species: (i) active drugs, (ii) diagnostic and (iii) theragnostic. We hope to provide a complete overview of the great potential of bismuth oxides in biological environments.

Indexed as

bismuth oxidechemotherapynanoparticlesradiopacitytheragnostic

Identifiers

PMID33228140
PMCPMC7699380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.